| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212334 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 30 Pages |
Abstract
Patients with TN treated with SRS reported significant improvements in multiple QOL measures, with the therapeutic benefit strongly driven by improvements in pain and/or discomfort and in self-care, along with lower rates of depression. In this analysis, there appears to be a correlation between prescription dose and treatment response as measured by the EQ-5D.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rupesh MD, Jacob A. BS, Sujith BS, Gene H. MD, MBA, Erin S. MD, Chandana A. MS, John H. MD, Gennady PhD, Andre MD, PhD, Sean MD, Samuel T. MD,